NO306700B1 - Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister - Google Patents

Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Info

Publication number
NO306700B1
NO306700B1 NO944214A NO944214A NO306700B1 NO 306700 B1 NO306700 B1 NO 306700B1 NO 944214 A NO944214 A NO 944214A NO 944214 A NO944214 A NO 944214A NO 306700 B1 NO306700 B1 NO 306700B1
Authority
NO
Norway
Prior art keywords
pct
rectal administration
alkylsulfonamides
agonists
pharmaceuticals
Prior art date
Application number
NO944214A
Other languages
English (en)
Norwegian (no)
Other versions
NO944214D0 (no
NO944214L (no
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of NO944214D0 publication Critical patent/NO944214D0/no
Publication of NO944214L publication Critical patent/NO944214L/no
Publication of NO306700B1 publication Critical patent/NO306700B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO944214A 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister NO306700B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (3)

Publication Number Publication Date
NO944214D0 NO944214D0 (no) 1994-11-04
NO944214L NO944214L (no) 1994-11-07
NO306700B1 true NO306700B1 (no) 1999-12-13

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944214A NO306700B1 (no) 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
CA2905541C (en) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2011316225B2 (en) 2010-10-15 2016-05-19 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
BR112014025907B1 (pt) 2012-04-18 2023-02-14 Contera Pharma Aps Formulação farmacêutica disponível para administração por via oral adequada para manejo aprimorado de transtornos do movimento
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
AU2017297718B2 (en) 2016-07-11 2023-06-08 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
FR2488606A1 (fr) * 1980-08-12 1982-02-19 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
DE3542698A1 (de) * 1984-12-04 1986-06-05 Glaxo Group Ltd., London Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
IL87437A0 (en) * 1987-08-13 1989-01-31 Glaxo Group Ltd Indole derivatives,their preparation and pharmaceutical compositions containing them
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
IL105468A0 (en) 1993-08-18
GB9309209D0 (en) 1993-06-16
SG46649A1 (en) 1998-02-20
IT1261471B (it) 1996-05-23
CZ272394A3 (en) 1995-10-18
CA2135179C (en) 2000-12-05
RU2118527C1 (ru) 1998-09-10
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
ITRM930286A1 (it) 1994-11-06
CY2039B1 (en) 1998-04-30
GB2266665A (en) 1993-11-10
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
CA2135179A1 (en) 1993-11-11
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
UA37206C2 (uk) 2001-05-15
HUT71418A (en) 1995-11-28
NZ252132A (en) 1996-09-25
ES2113533T3 (es) 1998-05-01
HK95697A (en) 1997-08-08
HU227338B1 (en) 2011-04-28
RO112993B1 (ro) 1998-03-30
IL105468A (en) 1998-09-24
CH685920A5 (fr) 1995-11-15
NO944214D0 (no) 1994-11-04
BR1100108A (pt) 1999-12-07
KR100253111B1 (en) 2000-07-01
GB2266665B (en) 1996-05-22
NO944214L (no) 1994-11-07
TW231970B (enExample) 1994-10-11
EP0639072A1 (en) 1995-02-22
IE930339A1 (en) 1993-11-17
AU4064093A (en) 1993-11-29
CZ283512B6 (cs) 1998-04-15
DE69317418T2 (de) 1998-07-30
GB9209882D0 (en) 1992-06-24
EP0639072B1 (en) 1998-03-11
IE75203B1 (en) 1997-08-27
OA10109A (en) 1996-12-18
BE1007024A5 (fr) 1995-02-21
WO1993021916A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
FR2690847B1 (fr) 1995-06-09
AU670083B2 (en) 1996-07-04
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
ZA933178B (en) 1994-01-10
BG62120B1 (bg) 1999-03-31

Similar Documents

Publication Publication Date Title
DE69932173D1 (de) Adenine-derivate
NO951613L (no) Ikke-peptidyl tachykinin reseptorantagonister
MX9702865A (es) Agentes estrogenicos.
NO944214L (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
NO20061737L (no) Aminosubstituerte erylamino B2 adrenergiske receptoragonister
ES2147758T3 (es) Preparacion sinergistica para la activacion de celulas destructoras naturales.
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
SE9702002D0 (sv) Novel compounds
TNSN98049A1 (fr) Composition pharmaceutique a residence gastrique.
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
NO950177D0 (no) Farmakologisk aktive erivater
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
DE59303446D1 (de) Neue bis-phenyl-hexene
ECSP972049A (es) Derivados de lactama
AR011169A1 (es) Compuestos derivados de quinoxalinadionas, su uso para la preparacion de medicamentos, compuestos intermediarios y procedimiento para preparar dichos medicamentos

Legal Events

Date Code Title Description
MK1K Patent expired